Medicine
Citanest Forte DENTAL 0.009 mg/72 mg per 1.8 mL injection
Citanest Forte DENTAL 0.009 mg/72 mg per 1.8 mL injection is a prescription medicine containing Epinephrine and Prilocaine for submucosal use, marketed by Dentsply Pharmaceutical, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C…
Key facts
- Active ingredient (INN)
- Epinephrine and Prilocaine
- Brand
- Citanest Forte DENTAL
- Strength
- 0.009 mg/72 mg per 1.8 mL
- Dosage form
- Injection
- Route
- Submucosal
- Packs
- 50 cartridges of 1.8 mL
- Marketing authorisation holder
- Dentsply Pharmaceutical
- Manufacturers
- Dentsply PharmaceuticalNovocol Pharmaceutical of Canada
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 4 December 2017
- Identifiers
- RxCUI 1596950, 1993224DailyMed set ID 801a4f80-397b-46c5-ad3e-a80594e7bda2, 60c8710b-ae55-4fdf-e053-2991aa0adc75NDC 51004-5801, 66312-580Application ANDA078959
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 50 cartridge in 1 carton / 1.8 mL in 1 cartridge | 66312-580-16 | Dentsply Pharmaceutical | 4 December 2017 |
| 50 cartridge in 1 carton / 1.8 mL in 1 cartridge | 51004-5801-6 | Novocol Pharmaceutical of Canada | 4 December 2017 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 18 November 1965 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Epinephrine and Prilocaine is a fixed-dose combination of an amide local anesthetic, a catecholamine and an alpha-adrenergic agonist indicated for the production of local anesthesia in dentistry by nerve block or infiltration techniques. MedsAcross supplies Epinephrine and Prilocaine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Epinephrine and PrilocaineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Citanest Forte DENTAL prescribing information (Novocol Pharmaceutical of Canada) · U.S. National Library of Medicine, DailyMed
Need Citanest Forte DENTAL 0.009 mg/72 mg per 1.8 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.